Want to join the conversation?
$GILD 2Q15 Call: In developing world, more than 30MM people are living with HIV & nearly 8MM now receive TDF-based treatment regimens. Switch data presented at IAS & TAF’s overall safety profile make it an important option for these patients. HCV: since Sovaldi’s approval, approx. 470K patients globally have started treatment with Sovaldi/Harvoni.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.